The Role of the MCTS1 and DENR Proteins in Regulating the Mechanisms Associated with Malignant Cell Transformation
Open Access
- 15 June 2021
- journal article
- review article
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 13 (2) , 98-105
Abstract
The mutations associated with malignant cell transformation are believed to disrupt the expression of a significant number of normal, non-mutant genes. The proteins encoded by these genes are involved in the regulation of many signaling pathways that are responsible for differentiation and proliferation, as well as sensitivity to apoptotic signals, growth factors, and cytokines. Abnormalities in the balance of signaling pathways can lead to the transformation of a normal cell, which results in tumor formation. Detection of the target genes and the proteins they encode and that are involved in the malignant transformation is one of the major evolutions in anti-cancer biomedicine. Currently, there is an accumulation of data that shed light on the role of the MCTS1 and DENR proteins in oncogenesis.Keywords
This publication has 69 references indexed in Scilit:
- Reinitiation and Other Unconventional Posttermination Events during Eukaryotic TranslationMolecular Cell, 2013
- The role of PARP in DNA repair and its therapeutic exploitationBritish Journal of Cancer, 2011
- Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recyclingGenes & Development, 2010
- GTP-independent tRNA Delivery to the Ribosomal P-site by a Novel Eukaryotic Translation FactorJournal of Biological Chemistry, 2010
- Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosisReproductive Biology and Endocrinology, 2008
- PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancerOncogene, 2008
- Identification of Transformation-Related Pathways in a Breast Epithelial Cell Model Using a Ribonomics ApproachCancer Research, 2008
- Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancerCancer and Metastasis Reviews, 2006
- Checkpoint Blockade in Cancer Immunotherapy2006
- Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancerOncogene, 2003